Certificate Of Analysis Bpc 157
Analytical transparency is critical when procuring synthetic peptides for preclinical laboratory models. A dedicated Certificate of Analysis provides quantitative proof of peptide sequence integrity, purity percentage, and endotoxin thresholds for every lot.
Quick answer
Analytical transparency is critical when procuring synthetic peptides for preclinical laboratory models. A dedicated Certificate of Analysis provides quantitative proof of peptide sequence integrity, purity percentage, and endotoxin thresholds for every lot.
Key takeaways
- A [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) for BPC-157 is an official laboratory document produced by an independent testing facility that details the analytical verification of a specific lot of the pentadecapeptide.
- A valid, comprehensive COA for research-grade [BPC-157](/research-peptides/bpc-157) must include several standardized metrics to ensure scientific reproducibility across experimental trials.
- High-Performance Liquid Chromatography (HPLC) is the gold standard method for determining the chemical purity of synthetic peptides.
- While HPLC measures purity relative to impurities, Mass Spectrometry (MS) verifies the exact chemical identity of the synthesized compound.
What is a Certificate of Analysis for BPC-157?
A Certificate of Analysis (COA) for BPC-157 is an official laboratory document produced by an independent testing facility that details the analytical verification of a specific lot of the pentadecapeptide. It provides objective quantitative data confirming the chemical identity, purity, molecular mass, and endotoxin profile of BPC-157 10mg prior to experimental use.
For principal investigators evaluating synthetic compounds, a third-party COA serves as the primary benchmark of quality assurance. Without lot-specific analytical documentation, researchers risk introducing confounding variables—such as unreacted peptide fragments, organic solvents, or bacterial lipopolysaccharides—into sensitive in vitro assays and animal models.
Essential Elements of an Authentic BPC-157 COA
A valid, comprehensive COA for research-grade BPC-157 must include several standardized metrics to ensure scientific reproducibility across experimental trials. When auditing documentation from a supplier, lab personnel should verify the presence of four core analytical components.
First, the document must display a clear lot number matching the physical vial, the manufacturing date, and the issue date from an accredited ISO 17025 laboratory. Second, it must feature a raw Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatogram showing peak resolution and integration. Third, an Electrospray Ionization Mass Spectrometry (ESI-MS) spectrum must be provided to confirm the molecular weight. Finally, quantitative results from a Chromogenic Limulus Amebocyte Lysate (LAL) assay must confirm that endotoxin content remains below acceptable thresholds for preclinical research.
Interpreting HPLC Purity Analysis for Synthetic Peptides
High-Performance Liquid Chromatography (HPLC) is the gold standard method for determining the chemical purity of synthetic peptides. In an RP-HPLC assay, the BPC-157 sample is passed through a hydrophobic stationary phase column under gradient elution. The resulting chromatogram plots UV absorbance (typically at 214 nm or 220 nm) against retention time.
Purity is calculated by integrating the area under the curve (AUC) for the primary BPC-157 peak relative to the total area of all detected peaks. High-purity compounds, such as those cataloged in our research peptide directory, exhibit a single dominant sharp peak representing ≥98.0% of the total integrated area. Minor secondary peaks represent truncated sequences or residual protecting groups, which must be minimized to avoid cross-reactivity in receptor binding studies.
Mass Spectrometry Verification of BPC-157 Molecular Identity
While HPLC measures purity relative to impurities, Mass Spectrometry (MS) verifies the exact chemical identity of the synthesized compound. BPC-157 is a 15-amino acid peptide with the primary sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and a theoretical monoisotopic molecular mass of approximately 1419.53 Da (or chemical formula C62H98N16O22).
An authentic mass spectrum confirms this molecular structure by identifying the mass-to-charge ratio (m/z). Typically, ESI-MS displays prominent charged species, such as the singly protonated [M+H]+ ion at 1420.5 m/z or doubly protonated [M+2H]2+ ion at 710.8 m/z. Alignment between the observed mass and calculated theoretical mass confirms that the correct sequence was assembled during solid-phase peptide synthesis (SPPS).
Endotoxin Testing and Safety Thresholds for In Vitro and Animal Studies
Endotoxins are lipopolysaccharides (LPS) derived from the outer cell membrane of Gram-negative bacteria, frequently introduced during peptide synthesis or purification processes. In cell culture models or animal tissue experiments, elevated endotoxin levels induce non-specific inflammatory signaling, interleukin release, and cell death, entirely obscuring biological response data.
A robust COA includes quantitative LAL test results expressed in Endotoxin Units per milligram (EU/mg). For rigorous preclinical investigation, research compounds should maintain endotoxin levels below 0.1 EU/mg to prevent immune activation in macrophage or endothelial cell cultures. PX1 Research mandates strict endotoxin testing across all batches to protect the integrity of your experimental data.
BPC-157 Biological Profile and Molecular Mechanisms
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a naturally occurring protective protein found in gastric juice. In preclinical models, BPC-157 is primarily studied for its role as a tissue repair modulator. Research indicates that its mechanism of action centers on upregulation of vascular endothelial growth factor (VEGF) expression, activation of the FAK-Paxillin signaling pathway, and stimulation of nitric oxide (NO) synthesis.
In vitro data demonstrate that BPC-157 accelerates endothelial cell migration and tube formation, key stages of angiogenesis. To explore detailed biochemical pathways and citations regarding this compound, researchers can review our dedicated guide on BPC-157 mechanisms.
Preclinical Findings in Connective Tissue and Gastrointestinal Models
Rodent and in vitro studies investigating BPC-157 demonstrate significant biological activity across multiple damaged tissue substrates. In connective tissue injury models involving the Achilles tendon, medial collateral ligament (MCL), and quadriceps muscle, administration of BPC-157 has been observed to accelerate fibroblast outgrowth, collagen type I synthesis, and structural tissue reorganization.
Additionally, rodent models of inflammatory bowel disease (IBD) and gastric ulceration show that BPC-157 promotes mucosal healing, protects mucosal integrity, and dampens pro-inflammatory cytokine expression. Researchers studying gastrointestinal barrier function and cellular repair frequently utilize high-purity BPC-157 to isolate these regenerative pathways.
Comparative Analysis: BPC-157 and Related Tissue Repair Peptides
When designing tissue regeneration assays, researchers often compare BPC-157 with other well-characterized repair compounds to evaluate synergistic or distinct signaling pathways. While BPC-157 primarily targets local angiogenesis and focal adhesion kinase activity, TB-500 10mg (a synthetic fragment of Thymosin Beta-4) acts predominantly via actin sequestration to promote cell motility and tissue remodeling. Similarly, GHK-Cu 50mg modulates gene expression related to extracellular matrix collagen synthesis and remodeling, whereas KPV exerts potent anti-inflammatory downstream signaling in epithelial lining models.
Understanding these distinct mechanism profiles allows investigators to select the appropriate single compound or combination protocol for target cell culture lines or animal histology models. Comprehensive technical specifications for these targets are accessible in our peptides research library.
Laboratory Reconstitution and Storage Protocols
Lyophilized BPC-157 must be reconstituted according to strict aseptic laboratory procedures to maintain peptide stability and prevent degradation. Lyophilized vials should be stored at -20°C or -80°C for long-term stability prior to reconstitution.
For experimental preparation, reconstitute the cake using laboratory-grade bacteriostatic water or sterile normal saline, directing the liquid slowly along the glass vial wall to prevent shearing forces. Avoid aggressive agitation; gently swirl the vial until complete dissolution occurs. Once reconstituted, liquid aliquots should be stored at 2°C to 8°C and used within 30 days, or sub-aliquoted and frozen to avoid repeated freeze-thaw cycles. For lab teams managing high-volume screening projects, specialized support is available via our wholesale peptide accounts.
PX1 Research Quality Assurance and Sourcing Commitment
PX1 Research enforces rigorous quality control standards across our entire supply chain. All research peptides are manufactured in GMP-compliant facilities located in the USA and subjected to independent ISO 17025 laboratory verification prior to distribution.
Every batch of BPC-157 is tested via RP-HPLC and mass spectrometry to confirm a purity benchmark of ≥98.0%, accompanied by lot-traceable COAs accessible directly to researchers. Orders ship same-day (Monday through Friday) from our California and Arizona fulfillment centers, ensuring rapid delivery to maintain cold-chain integrity and research schedules.
Frequently Asked Questions
What information should I look for on a BPC-157 COA?
A valid COA must show lot number, issue date, ISO 17025 accredited testing facility details, RP-HPLC chromatogram verifying purity ≥98%, mass spectrometry confirming molecular weight (~1419.5 Da), and LAL assay endotoxin levels (<0.1 EU/mg).
Why is third-party testing necessary for research peptides?
Third-party testing provides unbiased quantitative proof of purity, identity, and sterility. In-house COAs may lack rigor or mask impurities, residual solvents, or incorrect sequence synthesis that invalidate preclinical data.
What is the expected molecular mass of BPC-157 on Mass Spectrometry?
The theoretical monoisotopic mass of BPC-157 is 1419.53 Da. On an ESI-MS report, look for the primary protonated adducts such as [M+H]+ at ~1420.5 m/z or [M+2H]2+ at ~710.8 m/z.
What endotoxin limit is acceptable for BPC-157 in cell culture studies?
Endotoxin levels should ideally measure below 0.1 EU/mg (or <0.01 EU/μg). Higher endotoxin levels trigger non-specific immune signaling via Toll-like receptor 4 (TLR4) in macrophages and endothelial cells, distorting trial results.
How should lyophilized BPC-157 be stored upon arrival in the lab?
Lyophilized BPC-157 should be stored at -20°C or -80°C in a desiccated container away from light. Under these conditions, the dry powder remains stable for up to 24 months.
What solvent is recommended for reconstituting BPC-157 for in vitro work?
BPC-157 is highly soluble in aqueous solutions. Reconstitute using sterile bacteriostatic water, sterile 0.9% sodium chloride, or phosphate-buffered saline (PBS), depending on the requirements of your assay protocol.
How can I verify that my PX1 Research COA matches my product vial?
Each vial label features a printed lot code. Match this lot code to the COA database on the PX1 Research website or contact technical support to receive the exact analytical report for your specific batch.
Does PX1 Research provide bulk COAs for high-throughput screening?
Yes. Institutional accounts purchasing bulk research quantities receive lot-specific COAs for every item, alongside dedicated account handling through our wholesale program.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.